All individual numbers are from the SEC provided Financial Statement and Notes Data Sets. No guarantee is made for their accuracy. This report only shows the values that are common to a significant number of companies.
AKCEA THERAPEUTICS, INC.: Last Reported 3/31/2020

Business Address

22 BOSTON WHARF RD
9TH FLOOR
BOSTON, MA US 02210

Mailing Address

22 BOSTON WHARF RD
9TH FLOOR
BOSTON, MA US 02210
Phone Number: 617-207-0202 / State Incorporated: DE / Fiscal Year End 12/31

Balance Sheet

Date 3/31/2020 12/31/2019 9/30/2019 6/30/2019 3/31/2019 12/31/2018 9/30/2018 6/30/2018 3/31/2018 12/31/2017 9/30/2017 7/31/2017 6/30/2017 5/31/2017 3/31/2017 12/31/2016 9/30/2016 6/30/2016 3/31/2016 12/31/2015
Cash and Cash Equivalents $163,320,000.00 $306,866,000.00 $129,329,000.00 $150,234,000.00 $201,027,000.00 $86,454,000.00 $116,206,000.00 $216,840,000.00 $69,907,000.00 $58,367,000.00 $110,366,000.00 -- $75,445,000.00 -- $77,858,000.00 $7,857,000.00 $17,526,000.00 $32,808,000.00 -- $29,389,000.00
Accounts Receivable Net Current -- -- -- -- -- $4,597,000.00 -- -- -- $5,413,000.00 -- -- -- -- -- -- -- -- -- --
Inventory $13,723,000.00 $8,817,000.00 $8,641,000.00 $8,286,000.00 -- $85,000.00 -- -- -- -- -- -- -- -- -- -- -- -- -- --
Prepaid Expenses and Other Current Assets -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Total Current Assets $458,943,000.00 $496,905,000.00 $278,441,000.00 $327,711,000.00 $350,885,000.00 $267,235,000.00 $329,348,000.00 $388,721,000.00 $250,563,000.00 $266,845,000.00 $287,880,000.00 -- $122,607,000.00 -- -- $9,066,000.00 -- -- -- --
Property Plant and Equipement $5,437,000.00 $5,261,000.00 $5,277,000.00 $5,443,000.00 $5,336,000.00 $5,696,000.00 $5,757,000.00 $1,523,000.00 $50,000.00 $77,000.00 $104,000.00 -- $114,000.00 -- -- $177,000.00 -- -- -- --
Intangible Assets Net -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Goodwill -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Other Assets $3,084,000.00 $2,939,000.00 $3,620,000.00 $3,426,000.00 $3,426,000.00 $3,416,000.00 $3,054,000.00 $3,047,000.00 $661,000.00 $661,000.00 $114,000.00 -- $102,000.00 -- -- $100,000.00 -- -- -- --
Total Assets $559,921,000.00 $599,250,000.00 $383,167,000.00 $434,120,000.00 $458,717,000.00 $365,261,000.00 $379,128,000.00 $395,005,000.00 $252,465,000.00 $268,804,000.00 $289,349,000.00 -- $124,104,000.00 -- -- $10,684,000.00 -- -- -- --
Accounts Payable $10,372,000.00 $10,216,000.00 $5,711,000.00 $7,936,000.00 $6,153,000.00 $12,068,000.00 $3,071,000.00 $2,706,000.00 $2,578,000.00 $2,381,000.00 $2,012,000.00 -- $143,000.00 -- -- $476,000.00 -- -- -- --
Accrued Liabilities $14,131,000.00 $14,191,000.00 $15,211,000.00 $17,569,000.00 $17,255,000.00 $14,787,000.00 $21,151,000.00 $25,969,000.00 $13,413,000.00 $7,570,000.00 $3,452,000.00 -- $2,213,000.00 -- -- $1,041,000.00 -- -- -- --
Total Current Liabilities $50,230,000.00 $56,246,000.00 $57,679,000.00 $65,478,000.00 $69,853,000.00 $88,537,000.00 $97,717,000.00 $104,601,000.00 $106,165,000.00 $89,171,000.00 $91,506,000.00 -- $207,087,000.00 -- -- $28,431,000.00 -- -- -- --
Long Term Debt -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Additional Paid-in Capital $1,033,319,000.00 $1,024,168,000.00 $889,133,000.00 $900,837,000.00 $883,653,000.00 $799,001,000.00 $733,098,000.00 $678,509,000.00 $472,549,000.00 $464,430,000.00 $459,050,000.00 -- $64,059,000.00 -- -- $56,936,000.00 -- -- -- --
Accumulated Other Comprehensive Loss $391,000.00 $5,000.00 $-63,000.00 $-110,000.00 $-27,000.00 $-324,000.00 $-289,000.00 $-297,000.00 $-468,000.00 $-451,000.00 $-222,000.00 -- $-84,000.00 -- -- $-21,000.00 -- -- -- --
Accumulated Deficit $-524,120,000.00 $-481,270,000.00 $-563,676,000.00 $-532,178,000.00 $-494,855,000.00 $-522,042,000.00 $-451,485,000.00 $-387,894,000.00 $-325,848,000.00 $-284,413,000.00 $-261,052,000.00 -- $-246,958,000.00 -- -- $-174,662,000.00 -- -- -- --
Total Stockholders' Equity $509,691,000.00 $543,004,000.00 $325,488,000.00 $368,642,000.00 $388,864,000.00 $276,724,000.00 $281,411,000.00 $290,404,000.00 $146,300,000.00 $167,825,000.00 $197,843,000.00 -- $-82,983,000.00 -- -- $-17,747,000.00 -- -- -- --
Controlling Interest in Subsidiaries -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Total Liabilities and Equity $559,921,000.00 $599,250,000.00 $383,167,000.00 $434,120,000.00 $458,717,000.00 $365,261,000.00 $379,128,000.00 $395,005,000.00 $252,465,000.00 $268,804,000.00 $289,349,000.00 -- $124,104,000.00 -- -- $10,684,000.00 -- -- -- --

Statement of Operations

Date 3/31/2020 12/31/2019 9/30/2019 6/30/2019 3/31/2019 12/31/2018 9/30/2018 6/30/2018 3/31/2018 12/31/2017 9/30/2017 7/31/2017 6/30/2017 5/31/2017 3/31/2017 12/31/2016 9/30/2016 6/30/2016 3/31/2016 12/31/2015
Total Revenues -- -- -- -- -- -- -- -- -- $18,035,000.00 $13,449,000.00 -- $14,128,000.00 -- $9,597,000.00 -- -- -- -- --
Cost of Revenues -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Gross Profit -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Research and Development -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Selling, General, and Administrative $46,246,000.00 $181,681,000.00 $130,247,000.00 $50,740,000.00 $44,602,000.00 $153,610,000.00 $45,924,000.00 $42,287,000.00 $19,465,000.00 $36,981,000.00 $19,963,000.00 -- $6,915,000.00 -- $4,676,000.00 $15,053,000.00 -- -- -- --
Total Operating Expenses -- -- -- -- -- $82,255,000.00 $84,249,000.00 $81,744,000.00 $47,435,000.00 $163,871,000.00 $26,013,000.00 -- $94,872,000.00 -- $69,470,000.00 $83,512,000.00 $49,650,000.00 $29,748,000.00 $16,049,000.00 $61,438,000.00
Loss from Operations $-45,259,000.00 $83,163,000.00 $-45,089,000.00 $-38,706,000.00 $26,207,000.00 $-72,058,000.00 $-65,008,000.00 $-63,423,000.00 $-30,327,000.00 $-108,662,000.00 $-83,711,000.00 -- $-11,274,000.00 -- $-63,376,000.00 $-83,512,000.00 $-49,650,000.00 $-13,706,000.00 $-16,049,000.00 $-61,438,000.00
Loss Before Income Taxes -- -- -- -- -- -- -- -- -- -- $-12,028,000.00 -- -- -- -- -- $-49,380,000.00 -- -- --
Earnings Per Share Basic -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Weighted Average Shares Basic -- -- -- -- -- -- -- -- -- 46,010,777 59,173,938 -- -- -- -- 28,884,540 28,884,540 -- -- 28,884,540
Earnings Per Share Diluted -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Weighted Average Shares Diluted -- -- -- -- 94,127,942 -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Common Stock Shares Authorized 125,000,000 125,000,000 125,000,000 125,000,000 125,000,000 125,000,000 125,000,000 125,000,000 100,000,000 100,000,000 100,000,000 -- 100,000,000 40,000,000 -- 100,000,000 -- -- -- --
Common Stock Shares Outstanding 101,348,633 100,993,173 93,885,414 92,921,173 92,635,374 89,345,978 87,471,330 85,680,719 66,803,803 66,541,629 66,541,629 66,541,629 -- -- -- -- -- -- -- --
Copyright 2020 PursePoor.com